Search

Your search keyword '"Gallardo, David"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Gallardo, David" Remove constraint Author: "Gallardo, David" Database Unpaywall Remove constraint Database: Unpaywall
99 results on '"Gallardo, David"'

Search Results

1. Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity

2. Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort

3. CD200 genotype is associated with clinical outcome of patients with multiple myeloma

7. Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma

8. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

9. Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies

10. Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

11. Commissioning, on sky performance and first operations of JPCam, a 1.2 Gpixel camera for the wide-field 2.6m Javalambre Survey Telescope

12. Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

14. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

18. Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes

21. Acute Myeloid Leukemia with Isocitrate Dehydrogenases (IDH) 1 and 2 Mutations. a Real-World Study from the European IDH Research Group

22. Validation of the European Leukemianet 2017 Prognostic Classification for Patients with De Novo Acute Myeloid Leukemia Treated with a Risk-Adapted Protocol (CETLAM 2012)

23. Prospective Population-Based Analysis of Characteristics and Therapy Options in AML: The Case of Catalonia (PERIS Project)

24. Risk-Adapted Intensive Chemotherapy for Primary ACUTE Myeloid Leukemia during the Last 25 YEARS: Increase in Complete Remission RATE, Hematopoietic Cell Transplantation Access and Decrease in Relapse Incidence Have LED to Improved Survival

25. Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis

26. Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD

27. Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

30. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms

31. Commissioning and first scientific operations of the wide-field 2.6m Javalambre Survey Telescope

36. Bone marrowVEGFCexpression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival

37. Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches

40. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features

41. Lymphopenia and changes on peripheral blood immunophenotype in patients with hepatobiliarypancreatic tumors treated with chemoradiotherapy.

42. Highly variable mutational profile of ASXL1 in myelofibrosis

43. Prognostic Impact of MLL Partial Tandem Duplication in Acute Myeloid Leukemia of Intermediate Cytogenetic Risk: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

44. Favorable Outcome of Older Patients with AML and a Favorable Genotype NPM1mut FLT3-ITD Treated with Intensive Chemotherapy: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

45. A New Multiple Single-Nucleotide Polymorphisms Based Predictive Model for Grades III to IV and Extensive Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell

46. Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML

47. Labs R&D

48. Labs R&D

49. Co-existence ofJAK2V617F andCALRmutations in primary myelofibrosis

Catalog

Books, media, physical & digital resources